In the present study, we tested the estrogenomimetic effects of ICT, and confirmed the pharmacological effects of ICT on inhibiting osteoclast differentiation and anti-osteoporosis through in vivo and in vitro, and the expression of ESR1, ESR2 and miR-503 in OC was assessed. This evidence concerns the gene ESR2 and osteoporosis.